Business
Research Reports Initiated on Healthcare Stocks BELLUS Health, Resverlogix, Helius Medical Technologies, and IntelliPharmaCeutics International
LONDON, UK / ACCESSWIRE / March 29, 2017 / Active Wall St. announces the list of stocks for ...
About this update from Resverlogix Corp.
Research Reports Initiated on Healthcare Stocks BELLUS Health, Resverlogix, Helius Medical Technologies, and IntelliPharmaCeutics InternationalLONDON, UK / ACCESSWIRE / March 29, 2017 / Active Wall St. announces the list of stocks for today's research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Biotechnology industry. Companies recently under review include BELLUS Health, Resverlogix, Helius Medical Technologies, and IntelliPharmaCeutics International. Get all of our free research reports by signing up at: http://www.activewallst.com/register/ At the close of the Canadian markets on Tuesday, March 28, 2017, the Toronto Exchange Composite index ended the trading session at 15,598.57, 0.60% higher from its previous closing price. The Healthcare Index was in the red, closing the day at 67.85, down 0.29%. Active Wall St. has initiated research reports on the following equities: BELLUS Health Inc. (TSX: BLU), Resverlogix Corporation (TSX: RVX), Helius Medical Technologies Inc. (TSX: HSM), and IntelliPharmaCeutics International Inc. (TSX: IPCI). Register with us now for your free membership and research reports at: http://www.activewallst.com/register/ BELLUS Health Inc. Laval, Canada-based BELLUS Health Inc.'s stock declined 1.82%, to finish Tuesday's session at $0.27 with a total volume of 49,820 shares traded. Shares of the Company, which together with its subsidiaries, focuses on the research and development of drugs for rare diseases, are trading below its 50-day moving average. BELLUS Health's 50-day moving average of $0.28 is above its 200-day moving average of $0.27. See our research report on BLU.TO at: http://www.activewallst.com/register/ Resverlogix Corp. On Tuesday, shares in Calgary, Canada headquartered Resverlogix Corp. recorded a trading volume of 40,140 shares. The stock ended the day 3.60% higher at $2.30. Resverlogix's stock has surged 13.30% in the last one month and 37.72% in the previous three months. Furthermore, the stock has rallied 82.54% in the past one year. Shares of the Company, which develops small molecule therapeutics for Bromodomain and ExtraTerminal (BET) inhibition, are trading above its 50-day and 200-day moving averages. The stock's 50-day moving average of $2.04 is above its 200-day moving average of $1.89. T...